First-Trimester Screening for Neural Tube Defects Using Alpha-Fetoprotein

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Fetal Diagnosis and Therapy

• Publication date

  2012-02-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000335677PMID 22377693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein

  2011cited by this paper
• Turning the Pyramid of Prenatal Care

  2011cited by this paper
• Posterior brain in fetuses with open spina bifida at 11 to 13 weeks

  2011cited by this paper
• Maternal Serum α-Fetoprotein at 11–13 Weeks’ Gestation in Spontaneous Early Preterm Delivery

  2011cited by this paper
• Maternal Serum Alpha-Fetoprotein in Normal Pregnancy at 11–13 Weeks’ Gestation

  2011cited by this paper
• Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks

  2011cited by this paper
• Frontomaxillary facial angle in fetuses with spina bifida at 11–13 weeks' gestation

  2010cited by this paper
• Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11–13‐week scan

  2009cited by this paper
• Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.

  2008cited by this paper
• A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A

  1999cited by this paper
• Presence of the ‘lemon’ sign in fetuses with spina bifida at the 10–14‐week scan

  1997cited by this paper
• Serum alpha‐fetoprotein and neural tube defects in the first trimester of pregnancy

  1993cited by this paper
• First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects

  1993cited by this paper
• Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research Group.

  1993cited by this paper
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

  1992cited by this paper
• Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida.

  1990cited by this paper
• Ultrasound screening for spina bifida: cranial and cerebellar signs.

  1986cited by this paper
• An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

  1984cited by this paper
• An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

  1984cited by this paper
• Amniotic Fluid Acetylcholinesterase Electrophoresis as a Secondary Test in the Diagnosis of Anencephaly and Open Spina Bifida in Early Pregnancy: Report of the Collaborative Acetylcholinesterase Study

  1982cited by this paper
• Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.

  1981cited by this paper
• Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.

  1977cited by this paper
• Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy.

  1977cited by this paper
• Amniotic fluid alphafetoprotein measurements in the early prenatal diagnosis of central nervous system disorders

  1975cited by this paper
• A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS

  1975cited by this paper
• Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect.

  1975cited by this paper

• Predictive value of the maternal alpha-fetoprotein variant, L2, during the first trimester of pregnancy screening for fetal trisomy 21, trisomy 18, and neural tube defects

  2025cites this paper
• Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters

  2023cites this paper
• Sex difference in the associations among liver function parameters with incident diabetes mellitus in a large Taiwanese population follow-up study

  2023cites this paper
• Comparative study between 1st and 2nd trimester screening for neural tube defects using US markers and maternal serum alpha fetoportein

  2022cites this paper
• Design of Standard Value Intracranial Translucency of Fetus in Early Pregnancy Using Ultrasound

  2021influential citation
• AFP peptide (AFPep) as a potential growth factor for prostate cancer

  2021cites this paper
• Fetal spina bifida: What we tell the parents

  2020cites this paper
• Maternal weight as an additional first trimester spina bifida screening marker

  2020cites this paper
• Complement factors and alpha‐fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects

  2020cites this paper
• Indicaciones e interpretación del proteinograma

  2019cites this paper
• Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases.

  2019cites this paper
• Spina bifida screening in the first trimester using ultrasound biparietal diameter measurement adjusted for crown‐rump length or abdominal circumference

  2019cites this paper
• Laboratory options for risk assessment of pregnancy pathologies.

  2019cites this paper
• Normal intracranial BS/BSOB ratio values in the first trimester of single gestations with live fetuses in a Korean population.

  2017cites this paper
• The detection of spina bifida at 11–13+6 weeks' gestation

  2017cites this paper
• Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first

  2017cites this paper
• Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery

  2017cites this paper
• Sonographic detection of central nervous system defects in the first trimester of pregnancy

  2016cites this paper
• Additional Benefit of Α-Fetoprotein in Patients with Chronic Hepatitis B and C without Evidence of Hepatoma

  2015cites this paper
• Towards Detecting Open Spina Bifida in the First Trimester: The Examination of the Posterior Brain

  2015cites this paper
• Serum alpha‐fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history

  2015cites this paper
• Cell‐free fetal DNA screening in the USA: a cost analysis of screening strategies

  2015cites this paper
• Molecular signature of amniotic fluid derived stem cells in the fetal sheep model of myelomeningocele.

  2015cites this paper
• Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

  2015cites this paper
• Bölgesel Farklılıkların ve Gebeye Bağlı Faktörlerin Üçlü Test Üzerine Etkileri

  2014cites this paper
• The role of maternal serum α-fetoprotein in screening for open spina bifida at 11-13 weeks.

  2014cites this paper
• Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse.

  2014cites this paper
• First trimester maternal serum alpha‐fetoprotein is not raised in pregnancies with open spina bifida

  2014influential citation
• Correction for “ Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1 / CXCR 4 in breast cancer stem cells

  2014cites this paper
• Noninvasive in vivo monitoring of tissue-specific global gene expression in humans

  2014cites this paper
• Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects.

  2014cites this paper
• Prenatal prediction of need for ventriculoperitoneal shunt in open spina bifida

  2014cites this paper
• The incidence of preeclampsia and eclampsia in Australia: 2000 through 2008.

  2014cites this paper
• Is MSAFP Still a Useful Test for Detecting Open Neural Tube Defects and Ventral Wall Defects in the Era of First-Trimester and Early Second-Trimester Fetal Anatomical Ultrasounds?

  2014cites this paper
• Reply: To PMID 23673229.

  2014cites this paper
• Biparietal diameter at 11–13 weeks' gestation in fetuses with open spina bifida

  2013cites this paper
• The antiproliferative effect of mulberry ( Morus alba L.) plant on hepatocarcinoma cell line HepG2

  2013cites this paper
• Amniotic fluid and serum biomarkers from women with neural tube defect-affected pregnancies: a case study for myelomeningocele and anencephaly: clinical article.

  2013cites this paper
• Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers.

  2013cites this paper
• First‐trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell‐free DNA

  2013cites this paper
• Impact of prenatal screening on future resource utilization in pregnancy

  2012cites this paper
• Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter.

  2012cites this paper